Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Villar Alvarez, M. F. Troncoso-Acevedo, G. Peces-Barba, M. S. Lucero, I. Cabrejos-Salinas, Z. Saavedra-Moreno, N. González-Mangado (Madrid, Spain). Systemic inflammation and vascular dysfunction in patients with OSA. Eur Respir J 2011; 38: Suppl. 55, 2269

Member's Comments

No comment yet.

Related content which might interest you: Vascular dysfunction and systemic inflammation in patients with COPD Source: Annual Congress 2011 - COPD: human studies Year: 2011 Systemic inflammation and endothelial dysfunction in patient with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 143s Year: 2007 Systemic inflammation in OSA Source: Annual Congress 2009 - PG21 Morbidity and mortality of sleep-disordered breathing: jointly organised with ACCP Year: 2009 Systemic inflammation and endothelial dysfunction in patient with bronchial asthma Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Systemic inflammation and pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007 Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 Endothelial dysfunction as systemic effects of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006 Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 768s Year: 2007 Correction of endothelial dysfunction in patients with pulmonary diseases Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 Pulmonary arterial manifestation of systemic inflammation in patients with COPD Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 173s Year: 2001 Systemic endothelial dysfunction in COPD patients – study on 60 cases Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004 Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Systemic inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Endothelial dysfunction in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Endothelial dysfunction at the patients with COPD with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001 Systemic endothelial dysfunction in patients and first order relatives with pulmonary arterial hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004 Impaired endothelial vasoreactivity and markers of systemic inflammation in overlap syndrome Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013